Contrast Agent Injection
Contrast Agent Injection - Related Videos
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
0 Views •
Cited by 3 •
2013
To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.
07:15
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
0 Views •
Cited by 2 •
2013
We demonstrate how to perform macrophage MR imaging using ultrasmall superparamagnetic contrast agent (USPIO) in septic arthritis, allowing an initial and longitudinal in vivo non-invasive evaluation of macrophages infiltration and an assessment of therapy efficacy.
06:10
Injection of Microbubbles into Isolated Mouse Embryos: A Technique to Deliver Microbubble Contrast Agents into the Vasculature of Living Murine Embryos
0 Views •
2025
This video demonstrates a procedure to inject microbubble contrast agents into an isolated late gestation stage mouse embryo. The microbubble contrast agent-based ultrasound imaging helps visualize and characterize the vascular environment of the embryo.
13:21
Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 9 •
2011
We demonstrate the metalation, purification, and characterization of lanthanide complexes. The complexes described here can be conjugated to macromolecules to enable tracking of these molecules using magnetic resonance imaging.
FAQs
The two agent classes enhance images through different physical effects. Iodinated media increase X-ray attenuation, making structures appear more distinct on computed tomography and angiography. Gadolinium-based media alter local magnetic signals in magnetic resonance imaging, producing tissue-to-tissue differences. This distinction determines which contrast medium fits the imaging modality.
Injection timing controls whether the medium is present when the structure of interest is captured. Dose also affects the strength of the resulting image differences. Consequently, clinicians coordinate administration with image acquisition and select an appropriate amount for the examination. Poor alignment between injection and scanning can reduce the visibility of vessels, organs, or abnormal tissue.
Agent selection is tied to both the imaging technique and the diagnostic target. A study centered on X-ray attenuation, such as computed tomography or angiography, calls for an iodinated agent, whereas magnetic resonance imaging uses gadolinium-based agents to alter local magnetic signals. Matching agent and modality helps create interpretable tissue contrast for the intended assessment.
Monitoring is part of the injection process because image quality and patient safety depend on more than the medium itself. Clinical teams must consider the selected agent, dose, timing, and the patient during the examination. Observation supports a controlled procedure and helps clinicians maintain effective imaging practice while the contrast-enhanced study is performed.
Contrast-enhanced examinations can answer different clinical questions depending on what becomes more visible. They may help characterize lesions, assess vascular structures, identify inflammation, or guide diagnostic decisions. The value comes from relating the enhanced appearance to the clinical question, rather than treating contrast enhancement as a standalone finding.
A typical workflow links four decisions: choose the medium for the imaging modality, determine an appropriate dose, coordinate injection timing with image acquisition, and monitor the patient during the examination. These elements work together rather than independently. A technically successful injection is useful only when it produces diagnostically informative images for the intended clinical assessment.